Dermatology company Menlo amends IPO

Dermatology company Menlo Therapeutics Inc. (Menlo Park, Calif.) amended its proposed IPO on NASDAQ on Jan. 12 and now plans to sell 5.7 million shares at $14-$16. At the $15 midpoint, the company wou...